[1]
S. Stolz, “Introducing innovative cellular therapies into the clinic: a 2-year retrospective experience of a chimeric antigen receptor T-cell programme at a single centre in Switzerland”, Swiss Med Wkly, vol. 152, no. 2526, p. w30186, Jun. 2022.